# Efficacy and Safety of Early Use PCC in Severe Trauma

> **NCT05738642** · NA · COMPLETED · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 380 (actual)

## Conditions studied

- Severe Trauma
- Traumatic Shock

## Interventions

- **DRUG:** 4 factor Prothrombin Complex Concentrates

## Key facts

- **NCT ID:** NCT05738642
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-08-10
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-06-30
- **Target enrollment:** 380 (ACTUAL)
- **Last updated:** 2026-04-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05738642

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05738642, "Efficacy and Safety of Early Use PCC in Severe Trauma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05738642. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*